Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Cardiac Ablation Technology Market by Type (Radiofrequency, Cryoablation, Laser, Ultrasound, Microwave, Others), By Application (Cardiac Arrhythmia, Atrial Fibrillation, Tachycardia, Open Surgery) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Cardiac Ablation Technology Market by Type (Radiofrequency, Cryoablation, Laser, Ultrasound, Microwave, Others), By Application (Cardiac Arrhythmia, Atrial Fibrillation, Tachycardia, Open Surgery) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 137977 3300 Medical Devices & Consumables 377 237 Pages 4.6 (44)
                                          

Cardiac ablation is a procedure that is used to treat cardiac arrhythmias. It involves the use of catheters to destroy or disrupt the tissue that causes an arrhythmia. The procedure can be performed in a number of ways, including radiofrequency, cryoablation, laser, ultrasound and microwave. Radiofrequency ablation is the most common type of cardiac ablation and it uses heat generated by radio waves to destroy tissue. Cryoablation uses cold temperatures to freeze and kill tissue while laser ablation uses light energy from lasers to destroy tissue. Ultrasound ablation uses sound waves for treatment while microwave abilation delivers microwaves through catheters into the heart muscle for treatment. The global cardiac ablations market was valued at USD 3 billion in 2018 and is expected to reach USD 4 billion by 2030 with a CAGR of 5%. The market has been witnessing growth due to increasing prevalence of cardiovascular diseases such as atrial fibrillation (AF), tachycardia (TAC) and open surgery which are treated using this technology. Cardiac arrhythmias are also becoming more prevalent due to lifestyle changes such as increased stress levels, unhealthy diet habits etc, which has led physicians towards using this technology for treatment purposes. However, high cost associated with these procedures may hamper growth in some regions such as North America where healthcare costs are high compared with other regions like Asia Pacific where healthcare costs are comparatively lower than other regions globally. Cardiac ablation technology is a procedure that is used to treat arrhythmias. The procedure can be performed on patients who have had a heart attack, those with atrial fibrillation, and those with other types of arrhythmias.

Industry Growth Insights published a new data on “Cardiac Ablation Technology Market”. The research report is titled “Cardiac Ablation Technology Market research by Types (Radiofrequency, Cryoablation, Laser, Ultrasound, Microwave, Others), By Applications (Cardiac Arrhythmia, Atrial Fibrillation, Tachycardia, Open Surgery), By Players/Companies Abbott, AblaCor, Advanced Cardiac Therapeutics, AngioDynamics, AtriCure?Inc, Biosense Webster, Boston Scientific Corporation, CardioFocus, CONMED Corporation, Medtronic Plc, MicroPort Scientific Corporation, St. Jude Medical, Stryker Corporation”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Cardiac Ablation Technology Market Research Report

By Type

Radiofrequency, Cryoablation, Laser, Ultrasound, Microwave, Others

By Application

Cardiac Arrhythmia, Atrial Fibrillation, Tachycardia, Open Surgery

By Companies

Abbott, AblaCor, Advanced Cardiac Therapeutics, AngioDynamics, AtriCure?Inc, Biosense Webster, Boston Scientific Corporation, CardioFocus, CONMED Corporation, Medtronic Plc, MicroPort Scientific Corporation, St. Jude Medical, Stryker Corporation

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

237

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Cardiac Ablation Technology Industry Outlook


Global Cardiac Ablation Technology Market Report Segments:

The global Cardiac Ablation Technology market is segmented on the basis of:

Types

Radiofrequency, Cryoablation, Laser, Ultrasound, Microwave, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Cardiac Arrhythmia, Atrial Fibrillation, Tachycardia, Open Surgery

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott
  2. AblaCor
  3. Advanced Cardiac Therapeutics
  4. AngioDynamics
  5. AtriCure?Inc
  6. Biosense Webster
  7. Boston Scientific Corporation
  8. CardioFocus
  9. CONMED Corporation
  10. Medtronic Plc
  11. MicroPort Scientific Corporation
  12. St. Jude Medical
  13. Stryker Corporation

Global Cardiac Ablation Technology Market Overview


Highlights of The Cardiac Ablation Technology Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Radiofrequency
    2. Cryoablation
    3. Laser
    4. Ultrasound
    5. Microwave
    6. Others
  1. By Application:

    1. Cardiac Arrhythmia
    2. Atrial Fibrillation
    3. Tachycardia
    4. Open Surgery
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cardiac Ablation Technology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Cardiac Ablation Technology Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Cardiac ablation technology is a medical procedure that uses energy to destroy tissue in the heart. This can help to improve or correct heart function.

Some of the major companies in the cardiac ablation technology market are Abbott, AblaCor, Advanced Cardiac Therapeutics, AngioDynamics, AtriCure?Inc, Biosense Webster, Boston Scientific Corporation, CardioFocus, CONMED Corporation, Medtronic Plc, MicroPort Scientific Corporation, St. Jude Medical, Stryker Corporation.

The cardiac ablation technology market is expected to grow at a compound annual growth rate of 5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Cardiac Ablation Technology Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Cardiac Ablation Technology Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Cardiac Ablation Technology Market - Supply Chain
   4.5. Global Cardiac Ablation Technology Market Forecast
      4.5.1. Cardiac Ablation Technology Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Cardiac Ablation Technology Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Cardiac Ablation Technology Market Absolute $ Opportunity

5. Global Cardiac Ablation Technology Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Cardiac Ablation Technology Market Size and Volume Forecast by Type
      5.3.1. Radiofrequency
      5.3.2. Cryoablation
      5.3.3. Laser
      5.3.4. Ultrasound
      5.3.5. Microwave
      5.3.6. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Cardiac Ablation Technology Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Cardiac Ablation Technology Market Size and Volume Forecast by Application
      6.3.1. Cardiac Arrhythmia
      6.3.2. Atrial Fibrillation
      6.3.3. Tachycardia
      6.3.4. Open Surgery
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Cardiac Ablation Technology Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Cardiac Ablation Technology Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Cardiac Ablation Technology Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Cardiac Ablation Technology Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Cardiac Ablation Technology Demand Share Forecast, 2019-2029

9. North America Cardiac Ablation Technology Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Cardiac Ablation Technology Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Cardiac Ablation Technology Market Size and Volume Forecast by Application
      9.4.1. Cardiac Arrhythmia
      9.4.2. Atrial Fibrillation
      9.4.3. Tachycardia
      9.4.4. Open Surgery
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Cardiac Ablation Technology Market Size and Volume Forecast by Type
      9.7.1. Radiofrequency
      9.7.2. Cryoablation
      9.7.3. Laser
      9.7.4. Ultrasound
      9.7.5. Microwave
      9.7.6. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Cardiac Ablation Technology Demand Share Forecast, 2019-2029

10. Latin America Cardiac Ablation Technology Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Cardiac Ablation Technology Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Cardiac Ablation Technology Market Size and Volume Forecast by Application
      10.4.1. Cardiac Arrhythmia
      10.4.2. Atrial Fibrillation
      10.4.3. Tachycardia
      10.4.4. Open Surgery
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Cardiac Ablation Technology Market Size and Volume Forecast by Type
      10.7.1. Radiofrequency
      10.7.2. Cryoablation
      10.7.3. Laser
      10.7.4. Ultrasound
      10.7.5. Microwave
      10.7.6. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Cardiac Ablation Technology Demand Share Forecast, 2019-2029

11. Europe Cardiac Ablation Technology Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Cardiac Ablation Technology Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Cardiac Ablation Technology Market Size and Volume Forecast by Application
      11.4.1. Cardiac Arrhythmia
      11.4.2. Atrial Fibrillation
      11.4.3. Tachycardia
      11.4.4. Open Surgery
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Cardiac Ablation Technology Market Size and Volume Forecast by Type
      11.7.1. Radiofrequency
      11.7.2. Cryoablation
      11.7.3. Laser
      11.7.4. Ultrasound
     11.7.5. Microwave
      11.7.6. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Cardiac Ablation Technology Demand Share, 2019-2029

12. Asia Pacific Cardiac Ablation Technology Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Cardiac Ablation Technology Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Cardiac Ablation Technology Market Size and Volume Forecast by Application
      12.4.1. Cardiac Arrhythmia
      12.4.2. Atrial Fibrillation
      12.4.3. Tachycardia
      12.4.4. Open Surgery
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Cardiac Ablation Technology Market Size and Volume Forecast by Type
      12.7.1. Radiofrequency
      12.7.2. Cryoablation
      12.7.3. Laser
      12.7.4. Ultrasound
      12.7.5. Microwave
      12.7.6. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Cardiac Ablation Technology Demand Share, 2019-2029

13. Middle East & Africa Cardiac Ablation Technology Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Cardiac Ablation Technology Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Cardiac Ablation Technology Market Size and Volume Forecast by Application
      13.4.1. Cardiac Arrhythmia
      13.4.2. Atrial Fibrillation
      13.4.3. Tachycardia
      13.4.4. Open Surgery
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Cardiac Ablation Technology Market Size and Volume Forecast by Type
      13.7.1. Radiofrequency
      13.7.2. Cryoablation
      13.7.3. Laser
      13.7.4. Ultrasound
      13.7.5. Microwave
      13.7.6. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Cardiac Ablation Technology Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Cardiac Ablation Technology Market: Market Share Analysis
   14.2. Cardiac Ablation Technology Distributors and Customers
   14.3. Cardiac Ablation Technology Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Abbott
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. AblaCor
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Advanced Cardiac Therapeutics
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. AngioDynamics
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. AtriCure?Inc
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Biosense Webster
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Boston Scientific Corporation
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. CardioFocus
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. CONMED Corporation
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Medtronic Plc
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. MicroPort Scientific Corporation
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. St. Jude Medical
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Stryker Corporation
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us